Medical Care
Global AI in Surgery Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 16, 25
- ID: 546608
- Pages: 119
- Figures: 128
- Views: 3
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI in Surgery market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Activ Surgical, Inc.
Nanoflex
Caresyntax, Inc.
Surgalign
LeanTaaS Inc.
Medtronic Plc
Nvidia
Theator Inc.
Zimmer Biomet Holdings, Inc.
Segment by Type
Machine Learning
Deep Learning
Others
Segment by Application
Cardiovascular
Orthopedics
Neurosurgery
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI in Surgery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI in Surgery market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Activ Surgical, Inc.
Nanoflex
Caresyntax, Inc.
Surgalign
LeanTaaS Inc.
Medtronic Plc
Nvidia
Theator Inc.
Zimmer Biomet Holdings, Inc.
Segment by Type
Machine Learning
Deep Learning
Others
Segment by Application
Cardiovascular
Orthopedics
Neurosurgery
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI in Surgery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to AI in Surgery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI in Surgery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Machine Learning
1.2.3 Deep Learning
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global AI in Surgery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiovascular
1.3.3 Orthopedics
1.3.4 Neurosurgery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI in Surgery Revenue Estimates and Forecasts 2020-2031
2.2 Global AI in Surgery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI in Surgery Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI in Surgery Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Machine Learning Market Size by Players
3.3.2 Deep Learning Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global AI in Surgery Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI in Surgery Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI in Surgery Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI in Surgery Market Size by Type (2020-2031)
6.4 North America AI in Surgery Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI in Surgery Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI in Surgery Market Size by Type (2020-2031)
7.4 Europe AI in Surgery Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI in Surgery Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI in Surgery Market Size by Type (2020-2031)
8.4 Asia-Pacific AI in Surgery Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI in Surgery Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI in Surgery Market Size by Type (2020-2031)
9.4 Central and South America AI in Surgery Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI in Surgery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI in Surgery Market Size by Type (2020-2031)
10.4 Middle East and Africa AI in Surgery Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI in Surgery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Activ Surgical, Inc.
11.1.1 Activ Surgical, Inc. Corporation Information
11.1.2 Activ Surgical, Inc. Business Overview
11.1.3 Activ Surgical, Inc. AI in Surgery Product Features and Attributes
11.1.4 Activ Surgical, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.1.5 Activ Surgical, Inc. AI in Surgery Revenue by Product in 2024
11.1.6 Activ Surgical, Inc. AI in Surgery Revenue by Application in 2024
11.1.7 Activ Surgical, Inc. AI in Surgery Revenue by Geographic Area in 2024
11.1.8 Activ Surgical, Inc. AI in Surgery SWOT Analysis
11.1.9 Activ Surgical, Inc. Recent Developments
11.2 Nanoflex
11.2.1 Nanoflex Corporation Information
11.2.2 Nanoflex Business Overview
11.2.3 Nanoflex AI in Surgery Product Features and Attributes
11.2.4 Nanoflex AI in Surgery Revenue and Gross Margin (2020-2025)
11.2.5 Nanoflex AI in Surgery Revenue by Product in 2024
11.2.6 Nanoflex AI in Surgery Revenue by Application in 2024
11.2.7 Nanoflex AI in Surgery Revenue by Geographic Area in 2024
11.2.8 Nanoflex AI in Surgery SWOT Analysis
11.2.9 Nanoflex Recent Developments
11.3 Caresyntax, Inc.
11.3.1 Caresyntax, Inc. Corporation Information
11.3.2 Caresyntax, Inc. Business Overview
11.3.3 Caresyntax, Inc. AI in Surgery Product Features and Attributes
11.3.4 Caresyntax, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.3.5 Caresyntax, Inc. AI in Surgery Revenue by Product in 2024
11.3.6 Caresyntax, Inc. AI in Surgery Revenue by Application in 2024
11.3.7 Caresyntax, Inc. AI in Surgery Revenue by Geographic Area in 2024
11.3.8 Caresyntax, Inc. AI in Surgery SWOT Analysis
11.3.9 Caresyntax, Inc. Recent Developments
11.4 Surgalign
11.4.1 Surgalign Corporation Information
11.4.2 Surgalign Business Overview
11.4.3 Surgalign AI in Surgery Product Features and Attributes
11.4.4 Surgalign AI in Surgery Revenue and Gross Margin (2020-2025)
11.4.5 Surgalign AI in Surgery Revenue by Product in 2024
11.4.6 Surgalign AI in Surgery Revenue by Application in 2024
11.4.7 Surgalign AI in Surgery Revenue by Geographic Area in 2024
11.4.8 Surgalign AI in Surgery SWOT Analysis
11.4.9 Surgalign Recent Developments
11.5 LeanTaaS Inc.
11.5.1 LeanTaaS Inc. Corporation Information
11.5.2 LeanTaaS Inc. Business Overview
11.5.3 LeanTaaS Inc. AI in Surgery Product Features and Attributes
11.5.4 LeanTaaS Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.5.5 LeanTaaS Inc. AI in Surgery Revenue by Product in 2024
11.5.6 LeanTaaS Inc. AI in Surgery Revenue by Application in 2024
11.5.7 LeanTaaS Inc. AI in Surgery Revenue by Geographic Area in 2024
11.5.8 LeanTaaS Inc. AI in Surgery SWOT Analysis
11.5.9 LeanTaaS Inc. Recent Developments
11.6 Medtronic Plc
11.6.1 Medtronic Plc Corporation Information
11.6.2 Medtronic Plc Business Overview
11.6.3 Medtronic Plc AI in Surgery Product Features and Attributes
11.6.4 Medtronic Plc AI in Surgery Revenue and Gross Margin (2020-2025)
11.6.5 Medtronic Plc Recent Developments
11.7 Nvidia
11.7.1 Nvidia Corporation Information
11.7.2 Nvidia Business Overview
11.7.3 Nvidia AI in Surgery Product Features and Attributes
11.7.4 Nvidia AI in Surgery Revenue and Gross Margin (2020-2025)
11.7.5 Nvidia Recent Developments
11.8 Theator Inc.
11.8.1 Theator Inc. Corporation Information
11.8.2 Theator Inc. Business Overview
11.8.3 Theator Inc. AI in Surgery Product Features and Attributes
11.8.4 Theator Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.8.5 Theator Inc. Recent Developments
11.9 Zimmer Biomet Holdings, Inc.
11.9.1 Zimmer Biomet Holdings, Inc. Corporation Information
11.9.2 Zimmer Biomet Holdings, Inc. Business Overview
11.9.3 Zimmer Biomet Holdings, Inc. AI in Surgery Product Features and Attributes
11.9.4 Zimmer Biomet Holdings, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.9.5 Zimmer Biomet Holdings, Inc. Recent Developments
12 AI in SurgeryIndustry Chain Analysis
12.1 AI in Surgery Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI in Surgery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI in Surgery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to AI in Surgery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI in Surgery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Machine Learning
1.2.3 Deep Learning
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global AI in Surgery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiovascular
1.3.3 Orthopedics
1.3.4 Neurosurgery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI in Surgery Revenue Estimates and Forecasts 2020-2031
2.2 Global AI in Surgery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI in Surgery Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI in Surgery Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Machine Learning Market Size by Players
3.3.2 Deep Learning Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global AI in Surgery Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI in Surgery Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI in Surgery Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI in Surgery Market Size by Type (2020-2031)
6.4 North America AI in Surgery Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI in Surgery Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI in Surgery Market Size by Type (2020-2031)
7.4 Europe AI in Surgery Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI in Surgery Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI in Surgery Market Size by Type (2020-2031)
8.4 Asia-Pacific AI in Surgery Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI in Surgery Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI in Surgery Market Size by Type (2020-2031)
9.4 Central and South America AI in Surgery Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI in Surgery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI in Surgery Market Size by Type (2020-2031)
10.4 Middle East and Africa AI in Surgery Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI in Surgery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Activ Surgical, Inc.
11.1.1 Activ Surgical, Inc. Corporation Information
11.1.2 Activ Surgical, Inc. Business Overview
11.1.3 Activ Surgical, Inc. AI in Surgery Product Features and Attributes
11.1.4 Activ Surgical, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.1.5 Activ Surgical, Inc. AI in Surgery Revenue by Product in 2024
11.1.6 Activ Surgical, Inc. AI in Surgery Revenue by Application in 2024
11.1.7 Activ Surgical, Inc. AI in Surgery Revenue by Geographic Area in 2024
11.1.8 Activ Surgical, Inc. AI in Surgery SWOT Analysis
11.1.9 Activ Surgical, Inc. Recent Developments
11.2 Nanoflex
11.2.1 Nanoflex Corporation Information
11.2.2 Nanoflex Business Overview
11.2.3 Nanoflex AI in Surgery Product Features and Attributes
11.2.4 Nanoflex AI in Surgery Revenue and Gross Margin (2020-2025)
11.2.5 Nanoflex AI in Surgery Revenue by Product in 2024
11.2.6 Nanoflex AI in Surgery Revenue by Application in 2024
11.2.7 Nanoflex AI in Surgery Revenue by Geographic Area in 2024
11.2.8 Nanoflex AI in Surgery SWOT Analysis
11.2.9 Nanoflex Recent Developments
11.3 Caresyntax, Inc.
11.3.1 Caresyntax, Inc. Corporation Information
11.3.2 Caresyntax, Inc. Business Overview
11.3.3 Caresyntax, Inc. AI in Surgery Product Features and Attributes
11.3.4 Caresyntax, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.3.5 Caresyntax, Inc. AI in Surgery Revenue by Product in 2024
11.3.6 Caresyntax, Inc. AI in Surgery Revenue by Application in 2024
11.3.7 Caresyntax, Inc. AI in Surgery Revenue by Geographic Area in 2024
11.3.8 Caresyntax, Inc. AI in Surgery SWOT Analysis
11.3.9 Caresyntax, Inc. Recent Developments
11.4 Surgalign
11.4.1 Surgalign Corporation Information
11.4.2 Surgalign Business Overview
11.4.3 Surgalign AI in Surgery Product Features and Attributes
11.4.4 Surgalign AI in Surgery Revenue and Gross Margin (2020-2025)
11.4.5 Surgalign AI in Surgery Revenue by Product in 2024
11.4.6 Surgalign AI in Surgery Revenue by Application in 2024
11.4.7 Surgalign AI in Surgery Revenue by Geographic Area in 2024
11.4.8 Surgalign AI in Surgery SWOT Analysis
11.4.9 Surgalign Recent Developments
11.5 LeanTaaS Inc.
11.5.1 LeanTaaS Inc. Corporation Information
11.5.2 LeanTaaS Inc. Business Overview
11.5.3 LeanTaaS Inc. AI in Surgery Product Features and Attributes
11.5.4 LeanTaaS Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.5.5 LeanTaaS Inc. AI in Surgery Revenue by Product in 2024
11.5.6 LeanTaaS Inc. AI in Surgery Revenue by Application in 2024
11.5.7 LeanTaaS Inc. AI in Surgery Revenue by Geographic Area in 2024
11.5.8 LeanTaaS Inc. AI in Surgery SWOT Analysis
11.5.9 LeanTaaS Inc. Recent Developments
11.6 Medtronic Plc
11.6.1 Medtronic Plc Corporation Information
11.6.2 Medtronic Plc Business Overview
11.6.3 Medtronic Plc AI in Surgery Product Features and Attributes
11.6.4 Medtronic Plc AI in Surgery Revenue and Gross Margin (2020-2025)
11.6.5 Medtronic Plc Recent Developments
11.7 Nvidia
11.7.1 Nvidia Corporation Information
11.7.2 Nvidia Business Overview
11.7.3 Nvidia AI in Surgery Product Features and Attributes
11.7.4 Nvidia AI in Surgery Revenue and Gross Margin (2020-2025)
11.7.5 Nvidia Recent Developments
11.8 Theator Inc.
11.8.1 Theator Inc. Corporation Information
11.8.2 Theator Inc. Business Overview
11.8.3 Theator Inc. AI in Surgery Product Features and Attributes
11.8.4 Theator Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.8.5 Theator Inc. Recent Developments
11.9 Zimmer Biomet Holdings, Inc.
11.9.1 Zimmer Biomet Holdings, Inc. Corporation Information
11.9.2 Zimmer Biomet Holdings, Inc. Business Overview
11.9.3 Zimmer Biomet Holdings, Inc. AI in Surgery Product Features and Attributes
11.9.4 Zimmer Biomet Holdings, Inc. AI in Surgery Revenue and Gross Margin (2020-2025)
11.9.5 Zimmer Biomet Holdings, Inc. Recent Developments
12 AI in SurgeryIndustry Chain Analysis
12.1 AI in Surgery Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI in Surgery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI in Surgery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global AI in Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI in Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI in Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI in Surgery Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI in Surgery Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI in Surgery Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI in Surgery Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI in Surgery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Surgery as of 2024)
Table 11. Global AI in Surgery Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI in Surgery Companies Headquarters
Table 13. Global AI in Surgery Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI in Surgery Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI in Surgery Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI in Surgery Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI in Surgery Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI in Surgery High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI in Surgery Growth Accelerators and Market Barriers
Table 25. North America AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI in Surgery Growth Accelerators and Market Barriers
Table 27. Europe AI in Surgery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI in Surgery Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI in Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI in Surgery Investment Opportunities and Key Challenges
Table 31. Central and South America AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI in Surgery Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Activ Surgical, Inc. Corporation Information
Table 35. Activ Surgical, Inc. Description and Major Businesses
Table 36. Activ Surgical, Inc. Product Features and Attributes
Table 37. Activ Surgical, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Activ Surgical, Inc. Revenue Proportion by Product in 2024
Table 39. Activ Surgical, Inc. Revenue Proportion by Application in 2024
Table 40. Activ Surgical, Inc. Revenue Proportion by Geographic Area in 2024
Table 41. Activ Surgical, Inc. AI in Surgery SWOT Analysis
Table 42. Activ Surgical, Inc. Recent Developments
Table 43. Nanoflex Corporation Information
Table 44. Nanoflex Description and Major Businesses
Table 45. Nanoflex Product Features and Attributes
Table 46. Nanoflex Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Nanoflex Revenue Proportion by Product in 2024
Table 48. Nanoflex Revenue Proportion by Application in 2024
Table 49. Nanoflex Revenue Proportion by Geographic Area in 2024
Table 50. Nanoflex AI in Surgery SWOT Analysis
Table 51. Nanoflex Recent Developments
Table 52. Caresyntax, Inc. Corporation Information
Table 53. Caresyntax, Inc. Description and Major Businesses
Table 54. Caresyntax, Inc. Product Features and Attributes
Table 55. Caresyntax, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Caresyntax, Inc. Revenue Proportion by Product in 2024
Table 57. Caresyntax, Inc. Revenue Proportion by Application in 2024
Table 58. Caresyntax, Inc. Revenue Proportion by Geographic Area in 2024
Table 59. Caresyntax, Inc. AI in Surgery SWOT Analysis
Table 60. Caresyntax, Inc. Recent Developments
Table 61. Surgalign Corporation Information
Table 62. Surgalign Description and Major Businesses
Table 63. Surgalign Product Features and Attributes
Table 64. Surgalign Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Surgalign Revenue Proportion by Product in 2024
Table 66. Surgalign Revenue Proportion by Application in 2024
Table 67. Surgalign Revenue Proportion by Geographic Area in 2024
Table 68. Surgalign AI in Surgery SWOT Analysis
Table 69. Surgalign Recent Developments
Table 70. LeanTaaS Inc. Corporation Information
Table 71. LeanTaaS Inc. Description and Major Businesses
Table 72. LeanTaaS Inc. Product Features and Attributes
Table 73. LeanTaaS Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. LeanTaaS Inc. Revenue Proportion by Product in 2024
Table 75. LeanTaaS Inc. Revenue Proportion by Application in 2024
Table 76. LeanTaaS Inc. Revenue Proportion by Geographic Area in 2024
Table 77. LeanTaaS Inc. AI in Surgery SWOT Analysis
Table 78. LeanTaaS Inc. Recent Developments
Table 79. Medtronic Plc Corporation Information
Table 80. Medtronic Plc Description and Major Businesses
Table 81. Medtronic Plc Product Features and Attributes
Table 82. Medtronic Plc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Medtronic Plc Recent Developments
Table 84. Nvidia Corporation Information
Table 85. Nvidia Description and Major Businesses
Table 86. Nvidia Product Features and Attributes
Table 87. Nvidia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Nvidia Recent Developments
Table 89. Theator Inc. Corporation Information
Table 90. Theator Inc. Description and Major Businesses
Table 91. Theator Inc. Product Features and Attributes
Table 92. Theator Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Theator Inc. Recent Developments
Table 94. Zimmer Biomet Holdings, Inc. Corporation Information
Table 95. Zimmer Biomet Holdings, Inc. Description and Major Businesses
Table 96. Zimmer Biomet Holdings, Inc. Product Features and Attributes
Table 97. Zimmer Biomet Holdings, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Zimmer Biomet Holdings, Inc. Recent Developments
Table 99. Raw Materials Key Suppliers
Table 100. Distributors List
Table 101. Market Trends and Market Evolution
Table 102. Market Drivers and Opportunities
Table 103. Market Challenges, Risks, and Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. AI in Surgery Product Picture
Figure 2. Global AI in Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Machine Learning Product Picture
Figure 4. Deep Learning Product Picture
Figure 5. Others Product Picture
Figure 6. Global AI in Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Cardiovascular
Figure 8. Orthopedics
Figure 9. Neurosurgery
Figure 10. Others
Figure 11. AI in Surgery Report Years Considered
Figure 12. Global AI in Surgery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 14. Global AI in Surgery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global AI in Surgery Revenue Market Share by Region (2020-2031)
Figure 16. Global AI in Surgery Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Machine Learning Revenue Market Share by Player in 2024
Figure 19. Deep Learning Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global AI in Surgery Revenue Market Share by Type (2020-2031)
Figure 22. Global AI in Surgery Revenue Market Share by Application (2020-2031)
Figure 23. North America AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 25. North America AI in Surgery Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 27. US AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 28. Canada AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 30. Europe AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 32. Europe AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 35. France AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 37. Italy AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 38. Russia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 44. Japan AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 46. Australia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 47. India AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 55. Central and South America AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 61. South America AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 64. Israel AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 67. AI in Surgery Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global AI in Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI in Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI in Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI in Surgery Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI in Surgery Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI in Surgery Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI in Surgery Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI in Surgery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Surgery as of 2024)
Table 11. Global AI in Surgery Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI in Surgery Companies Headquarters
Table 13. Global AI in Surgery Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI in Surgery Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI in Surgery Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI in Surgery Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI in Surgery Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI in Surgery High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI in Surgery Growth Accelerators and Market Barriers
Table 25. North America AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI in Surgery Growth Accelerators and Market Barriers
Table 27. Europe AI in Surgery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI in Surgery Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI in Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI in Surgery Investment Opportunities and Key Challenges
Table 31. Central and South America AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI in Surgery Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI in Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Activ Surgical, Inc. Corporation Information
Table 35. Activ Surgical, Inc. Description and Major Businesses
Table 36. Activ Surgical, Inc. Product Features and Attributes
Table 37. Activ Surgical, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Activ Surgical, Inc. Revenue Proportion by Product in 2024
Table 39. Activ Surgical, Inc. Revenue Proportion by Application in 2024
Table 40. Activ Surgical, Inc. Revenue Proportion by Geographic Area in 2024
Table 41. Activ Surgical, Inc. AI in Surgery SWOT Analysis
Table 42. Activ Surgical, Inc. Recent Developments
Table 43. Nanoflex Corporation Information
Table 44. Nanoflex Description and Major Businesses
Table 45. Nanoflex Product Features and Attributes
Table 46. Nanoflex Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Nanoflex Revenue Proportion by Product in 2024
Table 48. Nanoflex Revenue Proportion by Application in 2024
Table 49. Nanoflex Revenue Proportion by Geographic Area in 2024
Table 50. Nanoflex AI in Surgery SWOT Analysis
Table 51. Nanoflex Recent Developments
Table 52. Caresyntax, Inc. Corporation Information
Table 53. Caresyntax, Inc. Description and Major Businesses
Table 54. Caresyntax, Inc. Product Features and Attributes
Table 55. Caresyntax, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Caresyntax, Inc. Revenue Proportion by Product in 2024
Table 57. Caresyntax, Inc. Revenue Proportion by Application in 2024
Table 58. Caresyntax, Inc. Revenue Proportion by Geographic Area in 2024
Table 59. Caresyntax, Inc. AI in Surgery SWOT Analysis
Table 60. Caresyntax, Inc. Recent Developments
Table 61. Surgalign Corporation Information
Table 62. Surgalign Description and Major Businesses
Table 63. Surgalign Product Features and Attributes
Table 64. Surgalign Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Surgalign Revenue Proportion by Product in 2024
Table 66. Surgalign Revenue Proportion by Application in 2024
Table 67. Surgalign Revenue Proportion by Geographic Area in 2024
Table 68. Surgalign AI in Surgery SWOT Analysis
Table 69. Surgalign Recent Developments
Table 70. LeanTaaS Inc. Corporation Information
Table 71. LeanTaaS Inc. Description and Major Businesses
Table 72. LeanTaaS Inc. Product Features and Attributes
Table 73. LeanTaaS Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. LeanTaaS Inc. Revenue Proportion by Product in 2024
Table 75. LeanTaaS Inc. Revenue Proportion by Application in 2024
Table 76. LeanTaaS Inc. Revenue Proportion by Geographic Area in 2024
Table 77. LeanTaaS Inc. AI in Surgery SWOT Analysis
Table 78. LeanTaaS Inc. Recent Developments
Table 79. Medtronic Plc Corporation Information
Table 80. Medtronic Plc Description and Major Businesses
Table 81. Medtronic Plc Product Features and Attributes
Table 82. Medtronic Plc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Medtronic Plc Recent Developments
Table 84. Nvidia Corporation Information
Table 85. Nvidia Description and Major Businesses
Table 86. Nvidia Product Features and Attributes
Table 87. Nvidia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Nvidia Recent Developments
Table 89. Theator Inc. Corporation Information
Table 90. Theator Inc. Description and Major Businesses
Table 91. Theator Inc. Product Features and Attributes
Table 92. Theator Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Theator Inc. Recent Developments
Table 94. Zimmer Biomet Holdings, Inc. Corporation Information
Table 95. Zimmer Biomet Holdings, Inc. Description and Major Businesses
Table 96. Zimmer Biomet Holdings, Inc. Product Features and Attributes
Table 97. Zimmer Biomet Holdings, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Zimmer Biomet Holdings, Inc. Recent Developments
Table 99. Raw Materials Key Suppliers
Table 100. Distributors List
Table 101. Market Trends and Market Evolution
Table 102. Market Drivers and Opportunities
Table 103. Market Challenges, Risks, and Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. AI in Surgery Product Picture
Figure 2. Global AI in Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Machine Learning Product Picture
Figure 4. Deep Learning Product Picture
Figure 5. Others Product Picture
Figure 6. Global AI in Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Cardiovascular
Figure 8. Orthopedics
Figure 9. Neurosurgery
Figure 10. Others
Figure 11. AI in Surgery Report Years Considered
Figure 12. Global AI in Surgery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 14. Global AI in Surgery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global AI in Surgery Revenue Market Share by Region (2020-2031)
Figure 16. Global AI in Surgery Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Machine Learning Revenue Market Share by Player in 2024
Figure 19. Deep Learning Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global AI in Surgery Revenue Market Share by Type (2020-2031)
Figure 22. Global AI in Surgery Revenue Market Share by Application (2020-2031)
Figure 23. North America AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 25. North America AI in Surgery Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 27. US AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 28. Canada AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 30. Europe AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 32. Europe AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 35. France AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 37. Italy AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 38. Russia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 44. Japan AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 46. Australia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 47. India AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore AI in Surgery Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 55. Central and South America AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa AI in Surgery Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players AI in Surgery Revenue (US$ Million) in 2024
Figure 61. South America AI in Surgery Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa AI in Surgery Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 64. Israel AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa AI in Surgery Revenue (2020-2025) & (US$ Million)
Figure 67. AI in Surgery Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Motor Brush Rocker Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Pediatric Mandibular Distractor System Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Automatic Coercive Force Meter Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232